Literature DB >> 9136782

Hepatic resection for hepatocellular carcinoma.

T Nonami1, A Harada, T Kurokawa, A Nakao, H Takagi.   

Abstract

BACKGROUND: The significance of pTNM staging of hepatocellular carcinoma (HCC) as a prognostic factor after hepatic resection was evaluated. PATIENTS AND METHODS: The prognoses were analyzed in 262 patients treated with hepatic resection for HCC.
RESULTS: As a whole, the pTNM stages correlated well with the survival rates. The survival rates of stage I and II patients were significantly higher than those of stages III and IV. However, there was no significant difference in survivals between stage I and II, and between stage III and IV-A. The survival rates of the patients treated with segmentectomy or lobectomy in stages I and II were significantly higher than those with subsegmentectomy or smaller resection. Multivariate analysis revealed that tumor size greater than 2 cm, multiple gross tumors, surgical margin less than 1 cm, and Child C classification were independently significant factors of poor survival.
CONCLUSIONS: The results of hepatic resection for HCC should be stratified by pTNM staging and by Child classification of hepatic function before comparison.

Entities:  

Mesh:

Year:  1997        PMID: 9136782     DOI: 10.1016/S0002-9610(96)00399-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 2.  Quality of complication reporting in the surgical literature.

Authors:  Robert C G Martin; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 4.  Localized hepatocellular carcinoma: therapeutic options.

Authors:  A Ribeiro; D M Nagorney; G J Gores
Journal:  Curr Gastroenterol Rep       Date:  2000-02

5.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 6.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival.

Authors:  Hsi-Huang Tseng; Yaw-Huei Hwang; Kun-Tu Yeh; Jan-Gowth Chang; Yao-Li Chen; Hsin-Su Yu
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-29       Impact factor: 4.553

8.  Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.

Authors:  Yuo-Chen Kuo; Maureen P Kohi; David M Naeger; Ricky T Tong; K Pallav Kolli; Andrew G Taylor; Jeanne M Laberge; Robert K Kerlan; Nicholas Fidelman
Journal:  Cardiovasc Intervent Radiol       Date:  2013-07-18       Impact factor: 2.740

9.  Multimodality treatment for patients with hepatocellular carcinoma: analysis of prognostic factors in a single Western institution series.

Authors:  H Medina-Franco; M T Sellers; D E Eckhoff; J S Bynon; M M Urist; M J Heslin
Journal:  J Gastrointest Surg       Date:  2001 Nov-Dec       Impact factor: 3.452

10.  Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.

Authors:  Theodoros Michelakos; Filippos Kontos; Yurie Sekigami; Motaz Qadan; Lei Cai; Onofrio Catalano; Vikram Deshpande; Madhukar S Patel; Teppei Yamada; Nahel Elias; Leigh Anne Dageforde; Shoko Kimura; Tatsuo Kawai; Kenneth K Tanabe; James F Markmann; Heidi Yeh; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.